Scholarlink

<p>Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a major cause of cancer-related deaths worldwide. Conventional diagnostics lack sensitivity for early detection. This review summarizes emerging biomarkers, advanced molecular classifications, and technologies such as RNA sequencing and liquid biopsy that enhance tumor characterization and monitoring. While promising, these approaches face validation and accessibility barriers. Their integration into clinical practice could enable personalized therapy and improve outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Decoding the molecular and genomic landscape of hepatocellular carcinoma: biomarker discovery, classification frameworks, and therapeutic targeting

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月1日

查看全文
  • Lorenzo Nevi,
  • Chiara Aiello,
  • Francesca Molinaro,
  • Annamaria Altomare,
  • Teresa Musarra,
  • Paolo Gallo,
  • Chiara Taffon,
  • Michele Pierluca Guarino,
  • Umberto Vespasiani-Gentilucci,
  • Andrea Baiocchini,
  • Simone Carotti

摘要

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a major cause of cancer-related deaths worldwide. Conventional diagnostics lack sensitivity for early detection. This review summarizes emerging biomarkers, advanced molecular classifications, and technologies such as RNA sequencing and liquid biopsy that enhance tumor characterization and monitoring. While promising, these approaches face validation and accessibility barriers. Their integration into clinical practice could enable personalized therapy and improve outcomes.